_id
69130154ccc777a4e85d7920
Ticker
IMMX
Name
Immix Biopharma Inc
Exchange
NASDAQ
Address
11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.immixbio.com
Description
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Last Close
6.205
Volume
72131
Current Price
5.85
Change
-5.7211925866236975
Last Updated
2025-12-01T09:18:27.112Z
Image
data:image/webp;base64,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
Ipo Date
2021-12-16T00:00:00.000Z
Market Cap
142705952
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.42333333333333334
Sentiment Sources
3
Rating
4
Target Price
5.95
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
7662509
Operating Income
-7662509
Interest Expense
-
Pretax Income
-7577970
Net Income
-7585692
Eps
-0.2375974855615141
Dividends Per Share
-
Shares Outstanding
33577873
Income Tax Expense
7722
EBITDA
-7480984
Operating Margin
-
Total Other Income Expense Net
84539
Cash
15947308
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
16584280
Property Plant Equipment
3364217
Total Assets
20080604
Payables
7050462
Short Term Debt
141282
Long Term Debt
-
Total Liabilities
11815634
Equity
8264970
Depreciation
134855
Change In Working Capital
1074590
Cash From Operations
-5905776
Capital Expenditures
372456
Cash From Investing
-372456
Cash From Financing
10608147
Net Change In Cash
4309363
PE
-
PB
27.31061607846127
ROE
-91.78124058526528
ROA
-37.77621430112361
FCF
-6278232
Fcf Percent
-
Piotroski FScore
1
Health Score
25
Deep Value Investing Score
2
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
7662509
Quarters > 0 > income Statement > operating Income
-7662509
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-7577970
Quarters > 0 > income Statement > net Income
-7585692
Quarters > 0 > income Statement > eps
-0.2375974855615141
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
31926651
Quarters > 0 > income Statement > income Tax Expense
7722
Quarters > 0 > income Statement > EBITDA
-7480984
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
84539
Quarters > 0 > balance Sheet > cash
15947308
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
16584280
Quarters > 0 > balance Sheet > property Plant Equipment
3364217
Quarters > 0 > balance Sheet > total Assets
20080604
Quarters > 0 > balance Sheet > payables
7050462
Quarters > 0 > balance Sheet > short Term Debt
141282
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
11815634
Quarters > 0 > balance Sheet > equity
8264970
Quarters > 0 > cash Flow > net Income
-7585692
Quarters > 0 > cash Flow > depreciation
134855
Quarters > 0 > cash Flow > change In Working Capital
1074590
Quarters > 0 > cash Flow > cash From Operations
-5905776
Quarters > 0 > cash Flow > capital Expenditures
372456
Quarters > 0 > cash Flow > cash From Investing
-372456
Quarters > 0 > cash Flow > cash From Financing
10608147
Quarters > 0 > cash Flow > net Change In Cash
4309363
Quarters > 0 > ratios > PE
-0.2375974855615141
Quarters > 0 > ratios > PB
27.31061607846127
Quarters > 0 > ratios > ROE
-91.78124058526528
Quarters > 0 > ratios > ROA
-37.77621430112361
Quarters > 0 > ratios > FCF
-6278232
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
79835
Quarters > 1 > income Statement > gross Profit
-79835
Quarters > 1 > income Statement > operating Expenses
6717705
Quarters > 1 > income Statement > operating Income
-6717705
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-6613649
Quarters > 1 > income Statement > net Income
-6622563
Quarters > 1 > income Statement > eps
-0.22087163572925667
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
29983764
Quarters > 1 > income Statement > income Tax Expense
8914
Quarters > 1 > income Statement > EBITDA
-6637870
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
104056
Quarters > 1 > balance Sheet > cash
11637945
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
12325460
Quarters > 1 > balance Sheet > property Plant Equipment
3178620
Quarters > 1 > balance Sheet > total Assets
15635104
Quarters > 1 > balance Sheet > payables
6614389
Quarters > 1 > balance Sheet > short Term Debt
70467
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
10982073
Quarters > 1 > balance Sheet > equity
4653031
Quarters > 1 > cash Flow > net Income
-6622563
Quarters > 1 > cash Flow > depreciation
79835
Quarters > 1 > cash Flow > change In Working Capital
700698
Quarters > 1 > cash Flow > cash From Operations
-5309781
Quarters > 1 > cash Flow > capital Expenditures
127630
Quarters > 1 > cash Flow > cash From Investing
-127630
Quarters > 1 > cash Flow > cash From Financing
1110116
Quarters > 1 > cash Flow > net Change In Cash
-4283156
Quarters > 1 > ratios > PE
-0.22087163572925667
Quarters > 1 > ratios > PB
45.558521204780284
Quarters > 1 > ratios > ROE
-142.3279363494462
Quarters > 1 > ratios > ROA
-42.35701278354145
Quarters > 1 > ratios > FCF
-5437411
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
21
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
59180
Quarters > 2 > income Statement > gross Profit
-59180
Quarters > 2 > income Statement > operating Expenses
4682925
Quarters > 2 > income Statement > operating Income
-4682925
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-4532706
Quarters > 2 > income Statement > net Income
-4542528
Quarters > 2 > income Statement > eps
-0.15294150919764535
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
29701080
Quarters > 2 > income Statement > income Tax Expense
9822
Quarters > 2 > income Statement > EBITDA
-4623745
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
150219
Quarters > 2 > balance Sheet > cash
15921101
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
16779244
Quarters > 2 > balance Sheet > property Plant Equipment
3092378
Quarters > 2 > balance Sheet > total Assets
19892040
Quarters > 2 > balance Sheet > payables
5742091
Quarters > 2 > balance Sheet > short Term Debt
67817
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
10298487
Quarters > 2 > balance Sheet > equity
9593553
Quarters > 2 > cash Flow > net Income
-4542528
Quarters > 2 > cash Flow > depreciation
59180
Quarters > 2 > cash Flow > change In Working Capital
1929849
Quarters > 2 > cash Flow > cash From Operations
-1685140
Quarters > 2 > cash Flow > capital Expenditures
67713
Quarters > 2 > cash Flow > cash From Investing
-67713
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-1760853
Quarters > 2 > ratios > PE
-0.15294150919764535
Quarters > 2 > ratios > PB
21.88830724133176
Quarters > 2 > ratios > ROE
-47.34979834895372
Quarters > 2 > ratios > ROA
-22.835908232639788
Quarters > 2 > ratios > FCF
-1752853
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
25
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
96290
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
48145
Quarters > 3 > income Statement > operating Expenses
4987120
Quarters > 3 > income Statement > operating Income
-4987120
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-4801269
Quarters > 3 > income Statement > net Income
-4812054
Quarters > 3 > income Statement > eps
-0.17472950273819698
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
27540020
Quarters > 3 > income Statement > income Tax Expense
10785
Quarters > 3 > income Statement > EBITDA
-4945783
Quarters > 3 > income Statement > operating Margin
-5179.270952331498
Quarters > 3 > income Statement > total Other Income Expense Net
185851
Quarters > 3 > balance Sheet > cash
17681954
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1974370
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
20197834
Quarters > 3 > balance Sheet > property Plant Equipment
2729620
Quarters > 3 > balance Sheet > total Assets
22947872
Quarters > 3 > balance Sheet > payables
5388494
Quarters > 3 > balance Sheet > short Term Debt
65219
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
9696669
Quarters > 3 > balance Sheet > equity
13251203
Quarters > 3 > cash Flow > net Income
-4812054
Quarters > 3 > cash Flow > depreciation
41337
Quarters > 3 > cash Flow > change In Working Capital
2588866
Quarters > 3 > cash Flow > cash From Operations
-1476198
Quarters > 3 > cash Flow > capital Expenditures
507152
Quarters > 3 > cash Flow > cash From Investing
-507151
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-2008477
Quarters > 3 > ratios > PE
-0.17472950273819698
Quarters > 3 > ratios > PB
14.693604905154649
Quarters > 3 > ratios > ROE
-36.31409163379355
Quarters > 3 > ratios > ROA
-20.969499917029346
Quarters > 3 > ratios > FCF
-1983350
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-20.597673694049227
Quarters > 3 > health Score
23
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
115388
Annuals > 0 > income Statement > gross Profit
-115388
Annuals > 0 > income Statement > operating Expenses
22674680
Annuals > 0 > income Statement > operating Income
-22674680
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-21657326
Annuals > 0 > income Statement > net Income
-21613376
Annuals > 0 > income Statement > eps
-0.7641113403244197
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
28285637
Annuals > 0 > income Statement > income Tax Expense
41037
Annuals > 0 > income Statement > EBITDA
-22559292
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1017354
Annuals > 0 > balance Sheet > cash
17681954
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1974370
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
20197834
Annuals > 0 > balance Sheet > property Plant Equipment
2729620
Annuals > 0 > balance Sheet > total Assets
22947872
Annuals > 0 > balance Sheet > payables
5388494
Annuals > 0 > balance Sheet > short Term Debt
65219
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
9696669
Annuals > 0 > balance Sheet > equity
13251203
Annuals > 0 > cash Flow > net Income
-21613376
Annuals > 0 > cash Flow > depreciation
115388
Annuals > 0 > cash Flow > change In Working Capital
3967300
Annuals > 0 > cash Flow > cash From Operations
-14595102
Annuals > 0 > cash Flow > capital Expenditures
1177678
Annuals > 0 > cash Flow > cash From Investing
-1177680
Annuals > 0 > cash Flow > cash From Financing
15948567
Annuals > 0 > cash Flow > net Change In Cash
172163
Annuals > 0 > ratios > PE
-0.7641113403244197
Annuals > 0 > ratios > PB
9.071927827986636
Annuals > 0 > ratios > ROE
-163.10501016398285
Annuals > 0 > ratios > ROA
-94.1846633971115
Annuals > 0 > ratios > FCF
-15772780
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
5468
Annuals > 1 > income Statement > gross Profit
-5468
Annuals > 1 > income Statement > operating Expenses
16141113
Annuals > 1 > income Statement > operating Income
-16141113
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-15569107
Annuals > 1 > income Statement > net Income
-15426048
Annuals > 1 > income Statement > eps
-0.889563405415271
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
17341145
Annuals > 1 > income Statement > income Tax Expense
26415
Annuals > 1 > income Statement > EBITDA
-16135645
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
572006
Annuals > 1 > balance Sheet > cash
17509791
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1172183
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
19787750
Annuals > 1 > balance Sheet > property Plant Equipment
50181
Annuals > 1 > balance Sheet > total Assets
19925160
Annuals > 1 > balance Sheet > payables
1433022
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3721783
Annuals > 1 > balance Sheet > equity
16405114
Annuals > 1 > cash Flow > net Income
-15595522
Annuals > 1 > cash Flow > depreciation
5468
Annuals > 1 > cash Flow > change In Working Capital
1652908
Annuals > 1 > cash Flow > cash From Operations
-11371438
Annuals > 1 > cash Flow > capital Expenditures
52089
Annuals > 1 > cash Flow > cash From Investing
-52089
Annuals > 1 > cash Flow > cash From Financing
15463512
Annuals > 1 > cash Flow > net Change In Cash
4073077
Annuals > 1 > ratios > PE
-0.889563405415271
Annuals > 1 > ratios > PB
4.492493392609158
Annuals > 1 > ratios > ROE
-94.03194637964722
Annuals > 1 > ratios > ROA
-77.41994543582084
Annuals > 1 > ratios > FCF
-11423527
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
-89517000
Annuals > 2 > income Statement > cost Of Revenue
2135
Annuals > 2 > income Statement > gross Profit
-89519135
Annuals > 2 > income Statement > operating Expenses
8218948
Annuals > 2 > income Statement > operating Income
-8218948
Annuals > 2 > income Statement > interest Expense
497
Annuals > 2 > income Statement > pretax Income
-8219445
Annuals > 2 > income Statement > net Income
-8229713
Annuals > 2 > income Statement > eps
-0.592606746202594
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
13887309
Annuals > 2 > income Statement > income Tax Expense
10268
Annuals > 2 > income Statement > EBITDA
-8216813
Annuals > 2 > income Statement > operating Margin
9.181438162583644
Annuals > 2 > income Statement > total Other Income Expense Net
-497
Annuals > 2 > balance Sheet > cash
13436714
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
255705
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
14897817
Annuals > 2 > balance Sheet > property Plant Equipment
3560
Annuals > 2 > balance Sheet > total Assets
14908101
Annuals > 2 > balance Sheet > payables
143074
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1748296
Annuals > 2 > balance Sheet > equity
13159805
Annuals > 2 > cash Flow > net Income
-8229713
Annuals > 2 > cash Flow > depreciation
2135
Annuals > 2 > cash Flow > change In Working Capital
195206
Annuals > 2 > cash Flow > cash From Operations
-7408303
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
3232063
Annuals > 2 > cash Flow > net Change In Cash
-4207764
Annuals > 2 > ratios > PE
-0.592606746202594
Annuals > 2 > ratios > PB
4.484949682005166
Annuals > 2 > ratios > ROE
-62.53673971612801
Annuals > 2 > ratios > ROA
-55.20295978676292
Annuals > 2 > ratios > FCF
-7408303
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
0.08275861568193751
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
2468
Annuals > 3 > income Statement > gross Profit
-2468
Annuals > 3 > income Statement > operating Expenses
1352014
Annuals > 3 > income Statement > operating Income
-1352014
Annuals > 3 > income Statement > interest Expense
179853
Annuals > 3 > income Statement > pretax Income
-24377866
Annuals > 3 > income Statement > net Income
-24383879
Annuals > 3 > income Statement > eps
-6.639385167664095
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3672611
Annuals > 3 > income Statement > income Tax Expense
6013
Annuals > 3 > income Statement > EBITDA
-24195545
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-23025852
Annuals > 3 > balance Sheet > cash
17644478
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
25722
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
18186393
Annuals > 3 > balance Sheet > property Plant Equipment
5695
Annuals > 3 > balance Sheet > total Assets
18192088
Annuals > 3 > balance Sheet > payables
142940
Annuals > 3 > balance Sheet > short Term Debt
50000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
202039
Annuals > 3 > balance Sheet > equity
17990049
Annuals > 3 > cash Flow > net Income
-24383879
Annuals > 3 > cash Flow > depreciation
2468
Annuals > 3 > cash Flow > change In Working Capital
-391035
Annuals > 3 > cash Flow > cash From Operations
-1589307
Annuals > 3 > cash Flow > capital Expenditures
802
Annuals > 3 > cash Flow > cash From Investing
-802
Annuals > 3 > cash Flow > cash From Financing
18848934
Annuals > 3 > cash Flow > net Change In Cash
17253392
Annuals > 3 > ratios > PE
-6.639385167664095
Annuals > 3 > ratios > PB
0.8676239153100694
Annuals > 3 > ratios > ROE
-135.54092598636055
Annuals > 3 > ratios > ROA
-134.03562581711347
Annuals > 3 > ratios > FCF
-1590109
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.2375974855615141
Valuation > metrics > PB
27.31061607846127
Valuation > final Score
20
Valuation > verdict
810.4% Overvalued
Profitability > metrics > ROE
-91.78124058526528
Profitability > metrics > ROA
-45.74025522965121
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.4296039792037962
Risk > metrics > Interest Coverage
-79.00634112139896
Risk > final Score
-286
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.306016454423294
Liquidity > metrics > Quick Ratio
2.306016454423294
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-1091
Prev Risks > 1
-176
Prev Risks > 2
-90
Prev Liquidities > 0
96
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T16:10:19.027Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.15
Earnings History > 0 > eps Difference
0.15
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-12-03
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.24
Earnings History > 1 > eps Estimate
-0.16
Earnings History > 1 > eps Difference
-0.08
Earnings History > 1 > surprise Percent
-50
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-03
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.22
Earnings History > 2 > eps Estimate
-0.21
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-4.7619
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-07
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.15
Earnings History > 3 > eps Estimate
-0.23
Earnings History > 3 > eps Difference
0.08
Earnings History > 3 > surprise Percent
34.7826
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.25
Earnings History > 4 > eps Estimate
-0.25
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
0
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-09
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.24
Earnings History > 5 > eps Estimate
-0.16
Earnings History > 5 > eps Difference
-0.08
Earnings History > 5 > surprise Percent
-50
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-11
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.15
Earnings History > 6 > eps Estimate
-0.21
Earnings History > 6 > eps Difference
0.06
Earnings History > 6 > surprise Percent
28.5714
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.2244
Earnings History > 7 > eps Estimate
-0.23
Earnings History > 7 > eps Difference
0.0056
Earnings History > 7 > surprise Percent
2.4348
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-29
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.23
Earnings History > 8 > eps Estimate
-0.23
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-13
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.23
Earnings History > 9 > eps Estimate
-0.23
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-11
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.24
Earnings History > 10 > eps Estimate
-0.17
Earnings History > 10 > eps Difference
-0.07
Earnings History > 10 > surprise Percent
-41.1765
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-12
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.18
Earnings History > 11 > eps Estimate
-0.14
Earnings History > 11 > eps Difference
-0.04
Earnings History > 11 > surprise Percent
-28.5714
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-27
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.27
Earnings History > 12 > eps Estimate
-0.22
Earnings History > 12 > eps Difference
-0.05
Earnings History > 12 > surprise Percent
-22.7273
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-09
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.1102
Earnings History > 13 > eps Estimate
-0.11
Earnings History > 13 > eps Difference
-0.0002
Earnings History > 13 > surprise Percent
-0.1818
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-12
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.11
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-13
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.1
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-28
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-3.16
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-12-17
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.02
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.02
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-09-17
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.16
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.16
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-06-30
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.1815
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.1815
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.1815
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.1815
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0345
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0345
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0394
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0394
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.0394
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.0394
Earnings History > 23 > surprise Percent
-
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AImmix Biopharma (NASDAQ:IMMX) Stock Rating Upgraded by Wall Street Zen Defense World
Read more →H.C. Wainwright Maintains Immix Biopharma(IMMX.US) With Buy Rating, Raises Target Price to $12 富途牛牛
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$5.95
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 11.26% of the total shares of Immix Biopharma Inc
1.
Bleichroeder LP(2.9479%)
since
2025/06/30
2.
Vanguard Group Inc(2.4226%)
since
2025/06/30
3.
Vanguard Total Stock Mkt Idx Inv(1.6946%)
since
2025/07/31
4.
Geode Capital Management, LLC(0.5588%)
since
2025/06/30
5.
Vanguard Institutional Extnd Mkt Idx Tr(0.4747%)
since
2025/07/31
6.
Morgan Stanley - Brokerage Accounts(0.4332%)
since
2025/06/30
7.
Northern Trust Corp(0.3256%)
since
2025/06/30
8.
Fidelity Extended Market Index(0.27%)
since
2025/07/31
9.
Susquehanna International Group, LLP(0.1763%)
since
2025/06/30
10.
State Street Corp(0.149%)
since
2025/06/30
11.
BlackRock Inc(0.1398%)
since
2025/06/30
12.
Timber Point Global Allocations Instl(0.1387%)
since
2025/06/30
13.
iShares Micro-Cap ETF(0.1272%)
since
2025/08/31
14.
Private Advisor Group, LLC(0.1083%)
since
2025/06/30
15.
Tocqueville Asset Management L.P.(0.1016%)
since
2025/06/30
16.
Velan Capital Investment Management LP(0.0867%)
since
2025/06/30
17.
TRITONPOINT WEALTH LLC(0.0851%)
since
2025/06/30
18.
Fidelity Total Market Index(0.0769%)
since
2025/07/31
19.
Fidelity Series Total Market Index(0.0701%)
since
2025/07/31
20.
NT Ext Equity Mkt Idx Fd - L(0.0694%)
since
2025/06/30
21.
Northern Trust Extended Eq Market Idx(0.0694%)
since
2025/06/30
22.
Spartan Extended Market Index Pool F(0.0683%)
since
2025/07/31
23.
NT Ext Equity Mkt Idx Fd - NL(0.0626%)
since
2025/06/30
24.
Virtu Financial LLC(0.0619%)
since
2025/06/30
25.
SBI Securities Co Ltd(0.0607%)
since
2025/06/30
26.
Northern Small Cap Core I(0.0581%)
since
2025/06/30
27.
Commonwealth Equity Services Inc(0.0556%)
since
2025/06/30
28.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0486%)
since
2025/06/30
29.
UBS Group AG(0.0485%)
since
2025/06/30
30.
Fidelity Nasdaq Composite Index(0.0476%)
since
2025/07/31
31.
The Colony Group LLC(0.0413%)
since
2025/06/30
32.
Royal Bank of Canada(0.0387%)
since
2025/06/30
33.
Spartan Total Market Index Pool G(0.0294%)
since
2025/07/31
34.
NT Quality Small Cap Core(0.0292%)
since
2025/06/30
35.
NT Quality SCC US Fund - L(0.0292%)
since
2025/06/30
36.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0196%)
since
2025/06/30
37.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0165%)
since
2024/12/31
38.
Shaker Financial Discount Capture(0.0156%)
since
2025/06/30
39.
Wells Fargo & Co(0.0011%)
since
2025/06/30
40.
Bank of America Corp(0.0005%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.15
Date
2025-09-30
EPS Actual
-0.24
EPS Estimate
-0.16
EPS Difference
-0.08
Surprise Percent
-50%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.